Product Introduction
Bioactivity


英文名: PU-H71

描述: PU-H71是一种选择性的HSP90抑制剂，IC50= 51 nM。

体外活性: PU-H71(1 μ M) 强效抑制三阴性乳腺癌(TNBC)细胞系MDA-MB-468、MDA-MB-231和HCC-1806的生长，其IC50值分别为65、140和87 nM。PU-H71(1 μ M)分别杀死MDA-MB-468、MDA-MB-231和HCC-1806细胞的80%、65%和80%[1]。

体内活性: MDA-MB-231 model treated with PU-H71 at a dose of 75 mg/kg was 100% fully effective. After 37 days of treatment, tumor was replaced by scar tissue, accompanied by a reduction in many proliferative and anti apoptotic molecules, such as EGFR, HER3, Raf-1, Akt, and p-Akt, which decreased by 80%, 95%, 99%, 80%, and 65%, respectively. PU-H71 (75 mg/kg, three times a week) inhibits tumor growth by 96%, reduces tumor cell proliferation by 60%, decreases activated Akt associated with survival and high invasive potential by 85%, and increases apoptosis by 6-fold[1].

存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 46.1 mg/mL (89.9 mM)


关键字: PU-H71 | PUH71 | PU H71

相关产品: Luminespib | Apoptozole | 4beta-Hydroxywithanolide E | XL888 | JG-98 | HA15 | AMP-PCP disodium | Geldanamycin | 3-Phenyltoxoflavin | TRAP1-IN-1